NCT06329258View on ClinicalTrials.gov

Combination of Sotyktu and Enstilar for Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions

Psoriasis

Interventions

DRUG

Enstilar

Add on Enstilar

DRUG

Deucravacitinib

6mg QD

Trial Locations (1)

08520

Schweiger Derm Group, East Windsor

All Listed Sponsors

lead

Psoriasis Treatment Center of Central New Jersey

OTHER